VAS
MRNA icon

Vestmark Advisory Solutions’s Moderna MRNA Stock Holding History

Vestmark Advisory Solutions’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7,029
Closed -$749K – 658
2024
Q4 		$749K Sell
7,029
-8,643
-55% -$413K 0.03% 361
2024
Q3 		$1.05M Sell
15,672
-2,388
-13% -$219K 0.04% 297
2024
Q2 		$2.14M Sell
18,060
-10,073
-36% -$1.27M 0.09% 233
2024
Q1 		$3M Buy
+28,133
New +$2.84M 0.13% 191
2023
Q1 		– Sell
-1,273
Closed -$229K – 892
2022
Q4 		$229K Buy
+1,273
New +$208K 0.01% 760
2022
Q1 		– Sell
-1,084
Closed -$275K – 887
2021
Q4 		$275K Buy
1,084
+564
+108% +$165K 0.02% 740
2021
Q3 		$200K Buy
+520
New +$192K 0.01% 796

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vestmark Advisory Solutions's MRNA Position: Q1 2025 in Review

Vestmark Advisory Solutions sold out of Moderna (MRNA) in Q1 2025, closing a stake of 7,029 shares — an estimated $749K sold.

Vestmark Advisory Solutions first reported a position in MRNA in Q3 2021 and held it in 7 quarters. The position peaked at $3M in Q1 2024. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • Vestmark Advisory Solutions reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • Vestmark Advisory Solutions sold 7,029 Moderna shares in Q1 2025, an estimated $749K.
  • Vestmark Advisory Solutions first reported a position in Moderna in Q3 2021 and held it in 7 quarters.
  • Vestmark Advisory Solutions's Moderna position peaked at $3M in Q1 2024.
  • 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on Vestmark Advisory Solutions's 13F filing for Q1 2025, filed 13 May 2025.